Childhood-onset systemic lupus erythematosus and immune thrombocytopenia: Prevalence and risk factors

被引:8
|
作者
Kittivisuit, Sirinthip [1 ]
Vachvanichsanong, Prayong [1 ]
McNeil, Edward [2 ]
Chotsampancharoen, Thirachit [1 ]
机构
[1] Prince Songkla Univ, Dept Pediat, Fac Med, Hat Yai 90110, Thailand
[2] Prince Songkla Univ, Epidemiol Unit, Fac Med, Hat Yai, Thailand
关键词
immune thrombocytopenia; risk factors; systemic lupus erythematosus; ANTINUCLEAR ANTIBODY-TEST; CLINICAL-SIGNIFICANCE; HIGH-TITER; CHILDREN; PURPURA; CRITERIA; ADULTS; CLASSIFICATION; FEATURES;
D O I
10.1002/pbc.29146
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background There are few studies examining the prevalence and clinical risk factors for subsequent systemic lupus erythematosus (SLE) development after long-term follow-up in childhood immune thrombocytopenia (ITP). The aims of this study were to evaluate the prevalence and risk factors for subsequent SLE development in childhood ITP. Methods The medical records of childhood ITP patients aged under 15 years in a major tertiary care center in Southern Thailand were retrospectively reviewed. The Kaplan-Meier method was used to estimate the cumulative probability of subsequent SLE development after ITP. Logistic regression analysis was used to identify independent risk factors for SLE development. Results A total of 473 childhood ITP cases were included in the study. During a mean follow-up time of 6.1 +/- 6.7 years, the prevalence of subsequent SLE development was 2.96%. Older age at ITP diagnosis (odds ratio [OR]: 1.24, 95% CI: 1.07-1.45) and chronic ITP (OR: 24.67, 95% CI: 3.14-100.0) were independent risk factors. The cumulative probabilities of subsequently developing SLE at 5 and 10 years after diagnosis of ITP were 3.8% (95% CI: 1.4-6.2) and 6.5% (95% CI: 2.9-9.8), respectively. Conclusion Older age at ITP diagnosis and chronic ITP were risk factors for subsequent SLE developed in childhood ITP.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus
    Thorbinson, Colin
    Oni, Louise
    Smith, Eve
    Midgley, Angela
    Beresford, Michael W.
    PEDIATRIC DRUGS, 2016, 18 (03) : 181 - 195
  • [42] Cost of treatment of childhood-onset systemic lupus erythematosus
    Brunner, HI
    Sherrard, TM
    Klein-Gitelman, MS
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (02): : 184 - 188
  • [43] Are prematurity and environmental factors determinants for developing childhood-onset systemic lupus erythematosus?
    Conde, Paola G.
    Farhat, Luis C.
    Braga, Alfesio L. F.
    Sallum, Adriana E. M.
    Farhat, Sylvia C. L.
    Silva, Clovis A.
    MODERN RHEUMATOLOGY, 2018, 28 (01) : 156 - 160
  • [44] Immune thrombocytopenia in systemic lupus erythematosus: Prevalence, risk factors, and a novel predictive model for risk assessment
    Lema, Jesus Cornudella
    Sanchez-Gonzalez, Blanca
    Carrion-Barbera, Irene
    de Oca, Sergio Vazquez Montes
    Pallarols, Francesc Garcia
    Salman-Monte, Tarek Carlos
    MEDICINA CLINICA, 2024, 162 (10): : 461 - 469
  • [45] Cancer risk in childhood-onset systemic lupus
    Bernatsky, Sasha
    Clarke, Ann E.
    Labrecque, Jeremy
    von Scheven, Emily
    Schanberg, Laura E.
    Silverman, Earl D.
    Brunner, Hermine I.
    Haines, Kathleen A.
    Cron, Randy Q.
    O'Neil, Kathleen M.
    Oen, Kiem
    Rosenberg, Alan M.
    Duffy, Ciaran M.
    Joseph, Lawrence
    Lee, Jennifer L.
    Kale, Mruganka
    Turnbull, Elizabeth M.
    Ramsey-Goldman, Rosalind
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (06)
  • [46] Cancer risk in childhood-onset systemic lupus
    Sasha Bernatsky
    Ann E Clarke
    Jeremy Labrecque
    Emily von Scheven
    Laura E Schanberg
    Earl D Silverman
    Hermine I Brunner
    Kathleen A Haines
    Randy Q Cron
    Kathleen M O’Neil
    Kiem Oen
    Alan M Rosenberg
    Ciarán M Duffy
    Lawrence Joseph
    Jennifer L Lee
    Mruganka Kale
    Elizabeth M Turnbull
    Rosalind Ramsey-Goldman
    Arthritis Research & Therapy, 15
  • [47] Prevalence and Clinical Significance of Hippocampal Atrophy in Childhood-Onset Systemic Lupus Erythematosus.
    Lapa, Aline T.
    Brabosa, Renata
    Postal, Mariana
    Sinicato, Nailu A.
    Marini, Roberto
    Cendes, Fernando
    Appenzeller, Simone
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S132 - S132
  • [48] Depressive and anxiety symptom prevalence in childhood-onset systemic lupus erythematosus: A systematic review
    Quilter, M. C.
    Hiraki, L. T.
    Korczak, D. J.
    LUPUS, 2019, 28 (07) : 878 - 887
  • [49] Evaluation of thyroid dysfunction in childhood-onset systemic lupus erythematosus: Risk factors for Hashimoto's thyroiditis
    Konte, Elif Kilic
    Karakas, Hasan
    Akay, Nergis
    Gul, Umit
    Ucak, Kubra
    Tarcin, Gurkan
    Aslan, Esma
    Gunalp, Aybuke
    Haslak, Fatih
    Turan, Oya Koker
    Yildiz, Mehmet
    Turan, Hande
    Ucar, Ayse Kalyoncu
    Adrovic, Amra
    Barut, Kenan
    Evliyaoglu, Olcay
    Sahin, Sezgin
    Kasapcopur, Ozgur
    LUPUS, 2024, 33 (11) : 1235 - 1241
  • [50] Depression and anxiety in childhood-onset systemic lupus erythematosus: prevalence, associated factors, and impact on quality of life and family
    Duangmala, Pitsamai
    Sontichai, Watchareewan
    PEDIATRIC RHEUMATOLOGY, 2025, 23 (01)